IDH1(R132H) Immunoexpression in Glioma
Background and objectives: Gliomas are the most common type of primary brain tumors. They result from accumu-- lation of multiple genetic alterations. Isocitrate dehydrogenase 1 mutations are detected in gliomas. This study aimed to assess IDH1 immunoexpression in different types of gliomas and to...
Saved in:
| Main Authors: | Nyan Saeed Omer, Jalal Ali Jalal, Ava Tahir Ismael |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kurdistan Higher Council Of Medical Specialties
2023-03-01
|
| Series: | Advanced Medical Journal |
| Subjects: | |
| Online Access: | https://amj.khcms.edu.krd/index.php/main/article/view/150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment
by: Hurais Malik, et al.
Published: (2024-09-01) -
Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy
by: Peng Wang, et al.
Published: (2025-04-01) -
IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study
by: Moez Eid, et al.
Published: (2025-05-01) -
Scaffold modification and synthesis routes for targeting mutant IDH 1: a review
by: Vasavi S. Pai, et al.
Published: (2025-07-01) -
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study
by: Nicolas Goliot, et al.
Published: (2025-08-01)